UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 4.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,742 shares of the medical instruments supplier’s stock after buying an additional 1,751 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in ICU Medical were worth $7,788,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Public Sector Pension Investment Board grew its holdings in ICU Medical by 15.1% during the third quarter. Public Sector Pension Investment Board now owns 51,854 shares of the medical instruments supplier’s stock worth $9,449,000 after acquiring an additional 6,800 shares during the period. MetLife Investment Management LLC boosted its position in shares of ICU Medical by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock worth $2,258,000 after purchasing an additional 6,981 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of ICU Medical by 16.5% in the third quarter. BNP Paribas Financial Markets now owns 6,997 shares of the medical instruments supplier’s stock valued at $1,275,000 after purchasing an additional 991 shares during the period. FMR LLC lifted its stake in shares of ICU Medical by 2,676.6% in the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after purchasing an additional 100,345 shares during the period. Finally, Cerity Partners LLC lifted its stake in shares of ICU Medical by 33.2% in the third quarter. Cerity Partners LLC now owns 9,846 shares of the medical instruments supplier’s stock valued at $1,794,000 after purchasing an additional 2,454 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Stock Up 3.6 %

Shares of NASDAQ:ICUI opened at $161.31 on Tuesday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.95 billion, a P/E ratio of -35.30 and a beta of 0.62. ICU Medical, Inc. has a 52-week low of $83.26 and a 52-week high of $196.26. The stock’s fifty day simple moving average is $172.37 and its 200-day simple moving average is $149.93.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ICUI. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp upped their price target on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Jefferies Financial Group started coverage on ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 target price on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Finally, Raymond James lifted their price target on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, ICU Medical currently has an average rating of “Moderate Buy” and an average price target of $173.00.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Friday, November 1st. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $17,973,261.12. This represents a 10.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, COO Christian B. Voigtlander sold 1,430 shares of the company’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total value of $225,940.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,364 shares of company stock valued at $6,869,878. 6.70% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.